FDA's Schwetz Is Acting Commissioner: Is RU-486 New Touchstone?
This article was originally published in The Gray Sheet
Executive Summary
Acting Deputy Commissioner Bernard Schwetz, PhD, will oversee the agency following the resignation of FDA Commissioner Jane Henney, MD.